Urology Devices

Protocol Design

Urology device trials require meticulous protocol design to account for anatomical variability, procedural complexity, and long-term functional outcomes. Key considerations include:

• Endpoint Selection: Functional outcomes (e.g., urinary flow rates, continence rates) and patient-reported outcomes (PROs) are critical for urology trials. STEMart collaborates with clinicians to define clinically meaningful endpoints.
• Procedural Standardization: Ensuring consistency in device implantation or usage across sites, particularly for robotic or laparoscopic devices.
• Control Group Design: Ethical considerations may limit the use of sham procedures, requiring innovative comparator strategies.

Ethical & Regulatory Compliance

Urology trials often involve sensitive procedures (e.g., prostate interventions, urinary stents), necessitating rigorous ethical oversight. Meditronics's services include:

• Pre-submission Strategy: Aligning with FDA (21 CFR 812), EU MDR, or NMPA requirements for urology-specific classifications (e.g., Class II/III devices).
• IRB/EC Coordination: Addressing patient privacy concerns (e.g., sexual function studies) and ensuring informed consent clarity for invasive procedures.

Site Selection & Investigator Engagement

Urology trials demand specialized sites with:

• Surgeon Expertise: High-volume centers proficient in device-specific techniques (e.g., ureteroscopy, sacral neuromodulation).
• Infrastructure: Access to urodynamic labs, imaging, and post-operative care facilities.

Meditronics leverages its global network to identify and qualify sites, ensuring rapid enrollment and protocol adherence.

Patient Recruitment

Recruiting urology patients requires targeted strategies:

• Disease-Specific Criteria: Enriching cohorts for conditions like BPH, OAB, or kidney stones, while accounting for comorbidities (e.g., diabetes impacting urinary outcomes).
• Retention Plans: Addressing dropout risks in long-term studies (e.g., 5-year follow-ups for prosthetic devices).

Meditronics employs digital outreach, physician referrals, and EHR-based screening to accelerate recruitment while maintaining data integrity.

Clinical Monitoring & Data Management

Urology trials generate complex data, including:

• Procedural Metrics: Operative time, device deployment accuracy.
• Post-Operative AE Tracking: Infections, device migrations, or voiding dysfunction.

Meditronics's monitors conduct frequent site visits, utilizing EDC systems with built-in checks for urology-specific data points (e.g., IPSS scores). Risk-based monitoring prioritizes high-risk procedures.

Post-Operative Follow-Up

Urology devices often require extended follow-up to assess durability and late-onset complications. Meditronics implements:

• Structured Visit Schedules: Aligned with healing phases (e.g., 3/6/12-month checkpoints for sling devices).
• PRO Collection: Validated questionnaires (e.g., IIEF, ICIQ) to capture quality-of-life impacts.